KDM6B and cancer: Although the role of this protein in these pathologies has not been fully described, JMJD3 is associated with the activity of different oncogenes such as NPM-ALK and BCL2, or tumor-suppressing genes such as BTG3 [89,177,178]; justifying the inclusion of this protein in the search for new anti-cancer epidrugs [179].